Dendritic cells (DC) are the main stimulators of primary T-cell responses a
nd, thus, probably play a role in the immune reactions after stem cell tran
splantation. Very little is known about DC in cord blood (CB) and about the
ir potential involvement in the low incidence and severity of acute graft-v
ersus-host disease after CB transplantation. Here, CBDC were identified as
a HLA-DR+ cell population, lacking the CD3, CD11b, CD14, CD16, CD19, CD34,
CD56, and glycophorin A lineage markers (lin). This lin(-)/HLA-DR+ populati
on represented 0.3% +/- 0.1% (mean +/- SD; range, 0.1% to 0.6%; n = 15) of
CB mononuclear cells, and CB contained 5.4 +/- 3.2 x 10(3) CBDC/mL (1.8 to
13.0 x 103; n = 15). CBDC expressed CD4, CD11a, CD18, CD45RA, CD50, CD54, a
nd CD123, but showed no expression of CD1a, CD11c, CD33, CD40, CD45R0, CD80
, CD83, end CD86 and only limited expression of CD58, CD102, and CD116. Des
pite this immature phenotype, immunomagnetically lin(-)-enriched CBDC were
potent stimulators of allogeneic CB T cells. As few as 266 +/- 107 (193 to
530; n = 10) lin-/HLA-DR+ CBDC stimulated a significant response. However,
CBDC failed to take up protein or peptide antigens. Thus, in CB there is a
prevalence of a DC subpopulation, resembling the CD11c(-) DC identified in
tonsils, the so-called plasmacytoid T cells, which may exert a function dis
tinct from the CD11c(+) DC subpopulation. (C) 1999 by The American Society
of Hematology.